Discovery of a novel orally active antidiabetic compound that improves peripheral insulin sensitivity in mice

被引：0
|
作者：
Marita, A. Rosalind
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A58 / A59
页数：2
相关论文
共 50 条
  • [21] Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes
    Cree-Green, Melanie
    Bergman, Bryan C.
    Cengiz, Eda
    Fox, Larry A.
    Hannon, Tamara S.
    Miller, Kellee
    Nathan, Brandon
    Pyle, Laura
    Kahn, Darcy
    Tansey, Michael
    Tichy, Eileen
    Tsalikian, Eva
    Libman, Ingrid
    Nadeau, Kristen J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08): : 3265 - 3278
  • [22] Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice
    Heijboer, AC
    van den Hoek, AM
    Parlevliet, ET
    Havekes, LM
    Romijn, JA
    Pijl, H
    Corssmit, EPM
    DIABETOLOGIA, 2006, 49 (04) : 732 - 738
  • [23] Effect of blocking VLDL on peripheral lipogenesis and insulin sensitivity in mice
    Minehira, K.
    Hellerstein, M. K.
    Thorens, B.
    Young, S. G.
    Tappy, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S42 - S42
  • [24] Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice
    A. C. Heijboer
    A. M. van den Hoek
    E. T. Parlevliet
    L. M. Havekes
    J. A. Romijn
    H. Pijl
    E. P. M. Corssmit
    Diabetologia, 2006, 49 : 732 - 738
  • [25] Discovery of a novel class of orally active CGRP receptor antagonists for the treatment of migraine
    Bell, Ian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [26] Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
    Brand, Stephen
    Cleghorn, Laura A. T.
    McElroy, Stuart P.
    Robinson, David A.
    Smith, Victoria C.
    Hallyburton, Irene
    Harrison, Justin R.
    Norcross, Neil R.
    Spinks, Daniel
    Bayliss, Tracy
    Norval, Suzanne
    Stojanovski, Laste
    Torrie, Leah S.
    Frearson, Julie A.
    Brenk, Ruth
    Fairlamb, Alan H.
    Ferguson, Michael A. J.
    Read, Kevin D.
    Wyatt, Paul G.
    Gilbert, Ian H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 140 - 152
  • [27] DISCOVERY OF A NOVEL CLASS OF ORALLY ACTIVE, NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS
    DE, B
    WINN, M
    ZYDOWSKY, TM
    KERKMAN, DJ
    DEBERNARDIS, JF
    LEE, J
    BUCKNER, S
    WARNER, R
    BRUNE, M
    HANCOCK, A
    OPGENORTH, T
    MARSH, K
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (20) : 3714 - 3717
  • [28] Discovery of novel orally active ureido NPYY5 receptor antagonists
    Li, Guoqing
    Stamford, Andrew W.
    Huang, Ying
    Cheng, Kuo-Chi
    Cook, John
    Farley, Constance
    Gao, Jun
    Ghibaudi, Lorraine
    Greenlee, William J.
    Guzzi, Mario
    van Heek, Margaret
    Hwa, Joyce J.
    Kelly, Joe
    Mullins, Deborra
    Parker, Eric M.
    Wainhaus, Sam
    Zhang, Xiaoping
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 1146 - 1150
  • [29] Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes
    Richter, Hans G. F.
    Benson, Gregory M.
    Blum, Denise
    Chaput, Evelyne
    Feng, Song
    Gardes, Christophe
    Grether, Uwe
    Hartman, Peter
    Kuhn, Bernd
    Martin, Rainer E.
    Plancher, Jean-Marc
    Rudolph, Markus G.
    Schuler, Franz
    Taylor, Sven
    Bleicher, Konrad H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 191 - 194
  • [30] Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor
    Imaeda, Yasuhiro
    Tokuhara, Hidekazu
    Fukase, Yoshiyuki
    Kanagawa, Ray
    Kajimoto, Yumiko
    Kusumoto, Keiji
    Kondo, Mitsuyo
    Snell, Gyorgy
    Behnke, Craig A.
    Kuroita, Takanobu
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 933 - 938
12345